Determinants of Resistance to First-line Therapy With an AI and Palbociclib for HR+ MBC
Condition: Breast Cancer Intervention: Drug: Aromatase Inhibitor and Palbociclib Sponsor: Sidney Kimmel Comprehensive Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology